http://www.cytokinetics.com
Cytokinetics, Incorporated Company Intro
Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.
Industry
Healthcare
Cytokinetics, Incorporated Headquaters
280 East Grand Avenue
South San Francisco,94080
United States
Cytokinetics, Incorporated Share price
22 Jan 2021 01:28 GMT
$20.01
0.03 (0.15 %)
Cytokinetics, Incorporated Market cap
$1.422 B
WMC RANKING
2021
Cytokinetics, Incorporated # 142
BiotechnologyLatest Cytokinetics, Incorporated News
23 Jan 2021
Robert I. Blum Sells 5000 Shares of Cytokinetics, Incorporated ...
Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Robert I. Blum sold 5,000 shares of the business's stock in a transaction on Wednesday, January 20th.
23 Jan 2021
Cytokinetics, Incorporated (CYTK) Is Worth A Look Now, Despite 50.02% Loss From High
Cytokinetics, Incorporated (NASDAQ:CYTK) concluded the trading at $20.36 on Friday, Jan 22, with a rise of 1.34% from its closing price on previous day.
23 Jan 2021
Robert I. Blum Sells 5000 Shares of Cytokinetics, Incorporated ...
Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Robert I. Blum sold 5,000 shares of the business's stock in a transaction on Wednesday, January 20th.
WMC Market Score
WMC Market to Revenue Score
Cytokinetics, Incorporated Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Cytokinetics, Incorporated | USD | $54,318 | $135,560 | $-114,000 | $14,220B | 142 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Cytokinetics, Incorporated Social Followers vs Top 4 Industry Competitors
Cytokinetics, Incorporated Post vs Top 4 Industry Competitors
Cytokinetics, Incorporated Digital Footprint By Size vs Top 4 Industry Competitors
Cytokinetics, Incorporated Digital Footprint By Change Rate vs Top 4 Industry Competitors
Cytokinetics, Incorporated WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Cytokinetics, Incorporated | 0.59 | 2.32 | 13.36 | 0 | 0 | 0 | 8.01 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
